SEC Form 4 · accession 0001209191-17-058644

HARVARD BIOSCIENCE INC · HBIO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Oct 30, 2017

Accepted (ET)

Nov 1, 2017 · 5:09 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001123494

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Nov 1, 2017	A	2,300	$0.00	A	2,300	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F3	$3.33	Oct 30, 2017	A	87,600	A	—	Oct 30, 2027	Common Stock, par value $0.01 per share	87,600	87,600	D

F1Represents a deferred stock award of 2,300 restricted stock units which vests on December 31, 2017. This retainer award was granted in lieu and satisfaction of the annual cash retainer compensation to be earned by the director for his service on the board and a committee of the Issuer's Board of Directors during 2017. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the applicable retainer all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of August, rounded to the nearest 100 shares.
F2Includes a deferred stock award of 2,300 restricted stock units which vests on December 31, 2017.
F3The options vest in three equal installments on October 30, 2018, 2019 and 2020.

This form has been signed under power of attorney.